Aug 7 (Reuters) - Kazia Therapeutics Ltd (KZA) :
- US FDA GRANTS RARE PEDIATRIC DISEASE DESIGNATION TO PAXALISIB FOR DIFFUSE INTRINSIC PONTINE GLIOMA
News: KZA Kazia Therapeutics Says U.S. FDA Grants Rare Pediatric Disease Designation To Paxalisib
Add to My Watchlist
What is My Watchlist?